US EditionUS Tariffs Raise Fears for European Pharmaceutical Sites
6 Articles
6 Articles
Manufacturers see risks for production, research and patients. Because US tariffs are not only a source of income for Washington. They are also intended to attract pharmaceutical companies to the United States.
Manufacturers see risks for production, research and patients. Because US tariffs are not only a source of income for Washington. They are also intended to attract pharmaceutical companies to the United States.
US tariffs raise fears for European pharmaceutical sites
Pharmaceutical manufacturers in Germany and Switzerland view the latest US tariffs on pharmaceutical products as a threat to their European production sites, representatives said on Friday, reported dpa. "In the medium term, there is a risk that parts of production and research will move to the US," where regulatory and financial incentives are attractive, said the Association of Research-Based Pharmaceutical Companies (VFA) in Berlin. The Swiss…
Manufacturers see risks for production, research, and patients. This is because the US tariffs are not just a source of revenue for Washington; they are also intended to attract pharmaceutical companies to the US.
Coverage Details
Bias Distribution
- 50% of the sources are Center, 50% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
